Anti-ALDH3A2 monoclonal antibody

Pre-made anti-ALDH3A2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ALDH3A2/ALDH3A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0018-Ab-1/ GM-Tg-hg-IP0018-Ab-2Anti-Human ALDH3A2 monoclonal antibodyHuman
GM-Tg-rg-IP0018-Ab-1/ GM-Tg-rg-IP0018-Ab-2Anti-Rat ALDH3A2 monoclonal antibodyRat
GM-Tg-mg-IP0018-Ab-1/ GM-Tg-mg-IP0018-Ab-2Anti-Mouse ALDH3A2 monoclonal antibodyMouse
GM-Tg-cynog-IP0018-Ab-1/ GM-Tg-cynog-IP0018-Ab-2Anti-Cynomolgus/ Rhesus macaque ALDH3A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0018-Ab-1/ GM-Tg-felg-IP0018-Ab-2Anti-Feline ALDH3A2 monoclonal antibodyFeline
GM-Tg-cang-IP0018-Ab-1/ GM-Tg-cang-IP0018-Ab-2Anti-Canine ALDH3A2 monoclonal antibodyCanine
GM-Tg-bovg-IP0018-Ab-1/ GM-Tg-bovg-IP0018-Ab-2Anti-Bovine ALDH3A2 monoclonal antibodyBovine
GM-Tg-equg-IP0018-Ab-1/ GM-Tg-equg-IP0018-Ab-2Anti-Equine ALDH3A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-IP0018-Ab-1/ GM-Tg-hg-IP0018-Ab-2; GM-Tg-rg-IP0018-Ab-1/ GM-Tg-rg-IP0018-Ab-2;
GM-Tg-mg-IP0018-Ab-1/ GM-Tg-mg-IP0018-Ab-2; GM-Tg-cynog-IP0018-Ab-1/ GM-Tg-cynog-IP0018-Ab-2;
GM-Tg-felg-IP0018-Ab-1/ GM-Tg-felg-IP0018-Ab-2; GM-Tg-cang-IP0018-Ab-1/ GM-Tg-cang-IP0018-Ab-2;
GM-Tg-bovg-IP0018-Ab-1/ GM-Tg-bovg-IP0018-Ab-2; GM-Tg-equg-IP0018-Ab-1/ GM-Tg-equg-IP0018-Ab-2
Products NameAnti-ALDH3A2 monoclonal antibody
Target NameALDH3A2
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
Products descriptionPre-made anti-ALDH3A2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0018-Ag-1Recombinant multi-species AL3A2/ ALDH3A2/ ALDH10 protein

    Target information

    Target IDGM-IP0018
    Target NameALDH3A2
    Gene ID224,65183,703661,119881481,101096617,513967,100073165
    Gene Symbol and SynonymsALDH10,ALDH3A2,Aldh4,FALDH,LOC119881481,SLS
    Uniprot AccessionP51648,P30839
    Uniprot Entry NameAL3A2_HUMAN,AL3A2_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    Gene EnsemblENSG00000072210
    Target ClassificationN/A

    The target: ALDH3A2, gene name: ALDH3A2, also named as ALDH10, FALDH, SLS. Aldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This gene product catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acid. Mutations in the gene cause Sjogren-Larsson syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.